Eardley Susan, Bishop Felicity L, Prescott Philip, Cardini Francesco, Brinkhaus Benno, Santos-Rey Koldo, Vas Jorge, von Ammon Klaus, Hegyi Gabriella, Dragan Simona, Uehleke Bernard, Fønnebø Vinjar, Lewith George
Complementary and Integrated Medicine Research Unit, University of Southampton, UK.
Forsch Komplementmed. 2012;19 Suppl 2:18-28. doi: 10.1159/000342708.
Studies suggest that complementary and alternative medicine (CAM) is widely used in the European Union (EU). We systematically reviewed data, reporting research quality and the prevalence of CAM use by citizens in Europe; what it is used for, and why.
We searched for general population surveys of CAM use by using Ovid MEDLINE (1948 to September 2010), Cochrane Library (1989 to September 2010), CINAHL (1989 to September 2010), EMBASE (1980 to September 2010), PsychINFO including PsychARTICLES (1989 to September 2010), Web of Science (1989 to September 2010), AMED (1985 to September 2010), and CISCOM (1989 to September 2010). Additional studies were identified through experts and grey literature. Cross-sectional, population-based or cohort studies reporting CAM use in any EU language were included. Data were extracted and reviewed by 2 authors using a pre-designed extraction protocol with quality assessment instrument.
87 studies were included. Inter-rater reliability was good (kappa = 0.8). Study methodology and quality of reporting were poor. The prevalence of CAM use varied widely within and across EU countries (0.3-86%). Prevalence data demonstrated substantial heterogeneity unrelated to report quality; therefore, we were unable to pool data for meta-analysis; our report is narrative and based on descriptive statistics. Herbal medicine was most commonly reported. CAM users were mainly women. The most common reason for use was dissatisfaction with conventional care; CAM was widely used for musculoskeletal problems.
CAM prevalence across the EU is problematic to estimate because studies are generally poor and heterogeneous. A consistent definition of CAM, a core set of CAMs with country-specific variations and a standardised reporting strategy to enhance the accuracy of data pooling would improve reporting quality.
研究表明,补充和替代医学(CAM)在欧盟(EU)广泛使用。我们系统地回顾了相关数据,报告了欧洲公民使用CAM的研究质量和流行情况;使用CAM的目的及原因。
我们通过检索Ovid MEDLINE(1948年至2010年9月)、Cochrane图书馆(1989年至2010年9月)、CINAHL(1989年至2010年9月)、EMBASE(1980年至2010年9月)、包括PsychARTICLES在内的PsychINFO(1989年至2010年9月)、科学引文索引(1989年至2010年9月)、AMED(1985年至2010年9月)以及CISCOM(1989年至2010年9月)来查找关于CAM使用情况的一般人群调查。通过专家和灰色文献确定了其他研究。纳入以任何欧盟语言报告CAM使用情况的横断面、基于人群或队列研究。由2位作者使用预先设计好的数据提取方案和质量评估工具来提取和审查数据。
纳入了87项研究。评分者间信度良好(kappa = 0.8)。研究方法和报告质量较差。欧盟国家内部和之间使用CAM的流行率差异很大(0.3% - 86%)。流行率数据显示出与报告质量无关的实质性异质性;因此,我们无法汇总数据进行荟萃分析;我们的报告是叙述性的,基于描述性统计。草药医学是最常被报告使用的。使用CAM的主要是女性。使用CAM最常见的原因是对传统医疗不满意;CAM广泛用于肌肉骨骼问题。
由于研究普遍质量差且异质性大,欧盟范围内CAM的流行率难以估计。对CAM的一致定义、一套具有国家特定差异的核心CAM以及标准化的报告策略以提高数据汇总的准确性,将改善报告质量。